RXRX Recursion Pharmaceuticals, Inc.
$3.00▼ -1.58%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$1.59B
P/E Ratio
–
Div Yield
–%
52W Range
2.77 - 7.18
% vs 50 MA
-7.35%
% vs 200 MA
-22.72%
RSI-14
42.8
MACD Histogram
-0.0400
Beta (1Y vs SPY)
2.87
Gross Rev
$66.41M
Gross Profit
-$428.74M
EBITDA
-$501.23M
COGS
$495.15M
Operating Exp
$72.49M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.84 · 62 posts
DDNewsThis might go to the moon
r/options · Jul 1, 2026
The author describes Recursion's technology as a revolutionary approach to drug discovery and highlights its large dataset and AI capabilities – indicating strong belief in the company’s future.
positive
+0.80
NewsDiscussionTelling yall rxrx to the moon
r/options · Jul 1, 2026
The post expresses a strong belief in RXRX's growth potential ('to the moon') and highlights key partnerships and investment.
very_positive
+1.00
TradeDiscussionDDPharma AI - might still be too early
r/wallstreetbets · May 4, 2026
The author highlights positive aspects of the company like AI drug discovery and significant backing. They describe it as an ‘AI-first’ play.
positive
+0.70
DDNewsTrade$RXRX: The AI Bio-God of 2026 or Why You’re a Moron for Buying Overpriced Index Funds
r/wallstreetbets · Feb 18, 2026
Strong bullish sentiment, framing the stock as a 'monster' and criticizing those buying index funds.
positive
+0.80
DDNewsDiscussionTrade$RXRX: The “NVIDIA” of Biology is Sitting at a Massive Discount
r/wallstreetbets · Jan 16, 2026
The post highlights NVIDIA's investment and collaboration, framing RXRX as a 'generational entry point' and a 'NVIDIA of Biology,' indicating strong bullish sentiment.
very_positive
+0.90
Page 1 of 13 (62 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.